AbbVie Inc.

0001000 - Document - Document and Entity Information

1001000 - Statement - Consolidated Statements of Earnings

1002000 - Statement - Consolidated Statements of Comprehensive Income

1002501 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)

1003000 - Statement - Consolidated Balance Sheets

1003501 - Statement - Consolidated Balance Sheets (Parenthetical)

1004000 - Statement - Consolidated Statements of Equity

1005000 - Statement - Consolidated Statements of Cash Flows

2101100 - Disclosure - Background and Basis of Presentation

2101100 - Disclosure - Summary of Significant Accounting Policies

2102100 - Disclosure - Supplemental Financial Information

2103100 - Disclosure - Earnings Per Share

2104100 - Disclosure - Licensing, Acquisitions, and Other Arrangements

2105100 - Disclosure - Collaboration with Janssen Biotech, Inc.

2106100 - Disclosure - Goodwill and Intangible Assets

2107100 - Disclosure - Restructuring Plans

2108100 - Disclosure - Leases

2110100 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies

2110100 - Disclosure - Financial Instruments and Fair Value Measures

2111100 - Disclosure - Post-Employment Benefits

2112100 - Disclosure - Equity

2113100 - Disclosure - Income Taxes

2114100 - Disclosure - Legal Proceedings and Contingencies

2115100 - Disclosure - Segment and Geographic Area Information

2116100 - Disclosure - Quarterly Financial Data (unaudited)

2201201 - Disclosure - Summary of Significant Accounting Policies (Policies)

2301302 - Disclosure - Summary of Significant Accounting Policies (Tables)

2302301 - Disclosure - Supplemental Financial Information (Tables)

2303301 - Disclosure - Earnings Per Share (Tables)

2305301 - Disclosure - Collaboration with Janssen Biotech, Inc. (Tables)

2306301 - Disclosure - Goodwill and Intangible Assets (Tables)

2307301 - Disclosure - Restructuring Plans (Tables)

2308301 - Disclosure - Leases (Tables)

2310301 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies (Tables)

2310301 - Disclosure - Financial Instruments and Fair Value Measures (Tables)

2311301 - Disclosure - Post-Employment Benefits (Tables)

2312301 - Disclosure - Equity (Tables)

2313301 - Disclosure - Income Taxes (Tables)

2315301 - Disclosure - Segment and Geographic Area Information (Tables)

2316301 - Disclosure - Quarterly Financial Data (unaudited) (Tables)

2401401 - Disclosure - Background and Basis of Presentation (Details)

2401403 - Disclosure - Summary of Significant Accounting Policies - Additional information (Details)

2401404 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Details)

2401405 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment, Net (Details)

2402402 - Disclosure - Supplemental Financial Information (Details)

2403402 - Disclosure - Earnings Per Share (Details)

2404401 - Disclosure - Licensing, Acquisitions, and Other Arrangements - Proposed Acquisition of Allergan plc (Details)

2404402 - Disclosure - Licensing, Acquisitions, and Other Arrangements - Other Licensing & Acquisitions Activity (Details)

2405402 - Disclosure - Collaboration with Janssen Biotech, Inc. (Details)

2406402 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)

2406403 - Disclosure - Goodwill and Intangible Assets - Summary of Intangible Assets (Details)

2406404 - Disclosure - Goodwill and Intangible Assets - Indefinite-Lived Intangible Assets (Details)

2406405 - Disclosure - Goodwill and Intangible Assets - Definite-Lived Intangible Assets (Details)

2407402 - Disclosure - Restructuring Plans (Details)

2408402 - Disclosure - Leases - Balance Sheet Disclosure (Details)

2408403 - Disclosure - Leases - Cost (Details)

2408404 - Disclosure - Leases - Weighted-Average Remaining Lease Term and Discount Rate (Details)

2408405 - Disclosure - Leases - Cash Flow Disclosure (Details)

2408406 - Disclosure - Leases - Maturities of Lease Liabilities (Details)

2410402 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies - Summary of Long-Term Debt (Details)

2410402 - Disclosure - Financial Instruments and Fair Value Measures - Financial Instruments (Details)

2410403 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies - Long-Term Debt - Additional Information (Details)

2410403 - Disclosure - Financial Instruments and Fair Value Measures - Amount of Gain/(Loss) Recognized For Derivative Instruments (Details)

2410404 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies - Short-Term Borrowings (Details)

2410404 - Disclosure - Financial Instruments and Fair Value Measures - Fair Value Measures (Details)

2410405 - Disclosure - Debt, Credit Facilities, and Commitments and Contingencies - Summary of Maturities of Long-Term Debt (Details)

2410405 - Disclosure - Financial Instruments and Fair Value Measures - Transfer of Assets or Liabilities Between The Fair Value Measurement Levels (Details)

2410406 - Disclosure - Financial Instruments and Fair Value Measures - Bases Used to Measure The Approximate Fair Value of Financial Instruments (Details)

2410407 - Disclosure - Financial Instruments and Fair Value Measures - Available-for-sale Securities (Details)

2410408 - Disclosure - Financial Instruments and Fair Value Measures - Concentrations of Risk (Details)

2411402 - Disclosure - Post-Employment Benefits - Additional Information (Details)

2411403 - Disclosure - Post-Employment Benefits - Benefit Plan Information (Details)

2411404 - Disclosure - Post-Employment Benefits - Pretax Gains and Losses Included in Other Comprehensive Income (Loss) (Details)

2411405 - Disclosure - Post-Employment Benefits - Net Periodic Benefit Cost (Details)

2411406 - Disclosure - Post-Employment Benefits - Weighted-Average Assumptions Used in Determining Benefit Obligation at Measurement Date (Details)

2411407 - Disclosure - Post-Employment Benefits - Weighted-Average Assumptions Used in Determining Net Periodic Benefit Cost (Details)

2411408 - Disclosure - Post-Employment Benefits - Effect of a One Percent Change in Assumed Health Care Cost Trend Rates (Details)

2411409 - Disclosure - Post-Employment Benefits - Defined Benefit Pension Plan Assets (Details)

2411410 - Disclosure - Post-Employment Benefits - Expected Defined Benefit and Other Post-Employment Plan Payments (Details)

2412402 - Disclosure - Equity - Stock-Based Compensation (Details)

2412403 - Disclosure - Equity - Stock Options (Details)

2412404 - Disclosure - Equity - RSUs and Performance Shares (Details)

2412405 - Disclosure - Equity - Cash Dividends (Details)

2412406 - Disclosure - Equity - Share Repurchase Program (Details)

2412407 - Disclosure - Equity - Accumulated Other Comprehensive Loss (Details)

2412408 - Disclosure - Equity - Amounts Reclassified Out Of Accumulated Other Comprehensive Loss (Details)

2412409 - Disclosure - Equity - Other (Details)

2413402 - Disclosure - Income Taxes - Earnings Before Income Tax Expense (Details)

2413403 - Disclosure - Income Taxes - Income Tax Expense (Details)

2413404 - Disclosure - Income Taxes - Impacts Related to U.S. Tax Reform (Details)

2413405 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)

2413406 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)

2413407 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)

2414401 - Disclosure - Legal Proceedings and Contingencies (Details)

2415402 - Disclosure - Segment and Geographic Area Information - Additional Information (Details)

2415403 - Disclosure - Segment and Geographic Area Information - Disaggregation of Revenue (Details)

2415404 - Disclosure - Segment and Geographic Area Information - Net Revenues to External Customers by Geographic Area (Details)

2415405 - Disclosure - Segment and Geographic Area Information - Long-lived Assets by Geographic Region (Details)

2416402 - Disclosure - Quarterly Financial Data (unaudited) (Details)